Calidi Biotherapeutics, Inc. Proceeds from Sale of Restricted Investments
Calidi Biotherapeutics, Inc. (CLDI) reported Proceeds from Sale of Restricted Investments of $622.29 thousand for the 6-month period ending 2023-06-30, per its 10-Q filed 2023-08-21.
Discontinued › Cash Flow › Investing Activities
us-gaap:ProceedsFromSaleOfRestrictedInvestments · last filed 2023-08-21
- 2023-06-30: Proceeds from Sale of Restricted Investments 6 month $622.29K.
- 2022-06-30: Proceeds from Sale of Restricted Investments 6 month $0.00.
| Period end | Proceeds from Sale of Restricted Investments 6 month |
|---|---|
| 2023-06-30 | $622.29K 10-Q · filed 2023-08-21 |
| 2022-06-30 | $0.00 10-Q · filed 2023-08-21 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |
| Silexion Therapeutics Corp (SLXN) | $0.001B | ||
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| AIM ImmunoTech Inc. (AIM) | United States | $0.006B | |
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |